Movement Alert|Cerebras Systems Falls 17.18% in Pre-Market Trading, Q2 Revenue and EPS Both Miss Estimates as Hardware Sales Drop 23%

Market Focus
Aug 13

On August 13, Cerebras Systems fell 17.18% in pre-market trading, trading at $216.27/share, with turnover of $1.88 million.

The decline was triggered by the company's Q2 earnings report released after market close the previous day. Cerebras posted quarterly revenue of $180.1 million, missing the analyst consensus estimate of approximately $190.6-$194.2 million. Adjusted EPS came in at a loss of $2.98, far worse than the expected loss of $1.41-$1.62. Hardware revenue fell 23% year-over-year to $54.1 million, serving as the primary drag on the top-line miss, while cloud computing services revenue surged 281% to $126 million.

Despite the company raising full-year revenue guidance to $880-$890 million and lifting adjusted gross margin expectations to 41%-43%, the significant Q2 shortfall triggered concentrated profit-taking among investors who had accumulated gains since the IPO. The net loss of $451 million was largely attributed to $387 million in stock-based compensation expenses. Management guided Q3 revenue of $214-$216 million, above the $210.2 million consensus.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10